Ionis (IONS) Climbs 5.53% for August 4

Equities Staff  |

Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares changed 5.53% today on 1,462,847 shares - while the stock has a 30 day average of 837,381 shares traded.

After today’s close at $43.29 the company has a 50 day moving average of $37.86.

The company expects its next earnings on 2022-08-09.

Ionis is up 34.80% so far this year.

For technical charts, analysis, and more on Ionis visit the company profile.

About Ionis Pharmaceuticals Inc

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.

To get more information on Ionis Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Ionis Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation

Market Movers

Sponsored Financial Content